- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1370
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1370 companies
Centessa Pharmaceuticals
Market Cap: US$3.2b
A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.
CNTA
US$23.01
7D
0.2%
1Y
46.8%
Joincare Pharmaceutical Group IndustryLtd
Market Cap: CN¥22.6b
Joincare Pharmaceutical Group Industry Co.,Ltd.
600380
CN¥12.36
7D
-4.8%
1Y
17.9%
Kalbe Farma
Market Cap: Rp52.9t
Develops, manufactures, and trades in pharmaceutical products in Indonesia.
KLBF
Rp1,145.00
7D
-1.3%
1Y
-34.2%
Jilin Aodong Pharmaceutical Group
Market Cap: CN¥22.5b
Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
CN¥19.15
7D
1.8%
1Y
29.7%
Prestige Consumer Healthcare
Market Cap: US$3.1b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$62.72
7D
-2.2%
1Y
-12.1%
Virbac
Market Cap: €2.6b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
VIRP
€310.50
7D
-0.8%
1Y
-20.5%
Mineralys Therapeutics
Market Cap: US$3.0b
A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
MLYS
US$38.51
7D
-3.4%
1Y
221.2%
NewAmsterdam Pharma
Market Cap: US$3.0b
A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.
NAMS
US$26.29
7D
-1.6%
1Y
66.1%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹261.5b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹1,669.95
7D
-1.2%
1Y
-11.5%
Perrigo
Market Cap: US$2.9b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$20.76
7D
-2.9%
1Y
-19.0%
Piramal Pharma
Market Cap: ₹258.9b
Operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.
PPLPHARMA
₹195.20
7D
-4.0%
1Y
-13.7%
Apellis Pharmaceuticals
Market Cap: US$2.9b
A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.
APLS
US$22.22
7D
-5.0%
1Y
-25.6%
Hybio Pharmaceutical
Market Cap: CN¥20.4b
Engages in the development, manufacture, and commercialization of therapeutic peptides API and peptide-based drugs in China and internationally.
300199
CN¥23.12
7D
-6.8%
1Y
137.1%
Indivior
Market Cap: US$2.9b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
US$22.81
7D
-0.3%
1Y
129.9%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س10.6b
Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.
4015
ر.س153.50
7D
1.0%
1Y
-22.9%
Almirall
Market Cap: €2.4b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
ALM
€11.30
7D
0.4%
1Y
28.2%
Xenon Pharmaceuticals
Market Cap: US$2.8b
A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.
XENE
US$36.52
7D
-3.3%
1Y
-4.9%
Emcure Pharmaceuticals
Market Cap: ₹250.2b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,325.80
7D
-1.1%
1Y
-7.4%
Bavarian Nordic
Market Cap: DKK 17.9b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 229.00
7D
-0.6%
1Y
-3.2%
CG Oncology
Market Cap: US$2.8b
A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.
CGON
US$36.48
7D
-6.0%
1Y
-0.8%
Ultragenyx Pharmaceutical
Market Cap: US$2.8b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
RARE
US$27.82
7D
-4.4%
1Y
-49.6%
Bora Pharmaceuticals
Market Cap: NT$84.2b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$678.00
7D
-3.0%
1Y
8.5%
Shandong Buchang Pharmaceuticals
Market Cap: CN¥19.6b
Shandong Buchang Pharmaceuticals Co., Ltd.
603858
CN¥18.62
7D
-3.5%
1Y
15.0%
BioArctic
Market Cap: SEK 25.8b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 290.80
7D
3.5%
1Y
78.1%
Hypera
Market Cap: R$14.6b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$23.05
7D
-4.0%
1Y
-13.7%
SK bioscienceLtd
Market Cap: ₩3.8t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩48,550.00
7D
-1.7%
1Y
-13.6%
China Resources Double-Crane PharmaceuticalLtd
Market Cap: CN¥19.3b
China Resources Double-Crane Pharmaceutical Co.,Ltd.
600062
CN¥18.81
7D
-1.5%
1Y
-12.5%
InventisBio
Market Cap: CN¥19.3b
A clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States.
688382
CN¥33.40
7D
-2.7%
1Y
323.3%
HUTCHMED (China)
Market Cap: UK£2.0b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£2.35
7D
-11.0%
1Y
-14.2%
Keymed Biosciences
Market Cap: HK$20.9b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$71.00
7D
-6.9%
1Y
91.6%
Kiniksa Pharmaceuticals International
Market Cap: US$2.7b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$35.51
7D
-1.1%
1Y
48.2%
BGI Genomics
Market Cap: CN¥19.0b
Provides genomic sequencing and proteomic services in China and internationally.
300676
CN¥49.58
7D
-2.9%
1Y
32.0%
Apeloa PharmaceuticalLtd
Market Cap: CN¥19.0b
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.
000739
CN¥16.53
7D
-0.7%
1Y
12.2%
Supernus Pharmaceuticals
Market Cap: US$2.6b
A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$47.18
7D
2.3%
1Y
53.3%
Shenzhen Kangtai Biological Products
Market Cap: CN¥18.7b
Shenzhen Kangtai Biological Products Co., Ltd.
300601
CN¥16.70
7D
-4.7%
1Y
11.4%
Walvax Biotechnology
Market Cap: CN¥18.6b
Engages in the research and development, manufacture, and distribution of vaccines in China.
300142
CN¥11.63
7D
-4.7%
1Y
4.6%